Daniel P. van Plew Net Worth & Insider Trades
Daniel P. van Plew - EVP & General Mgr, Regeneron Pharmaceuticals, Inc
What is Daniel P. van Plew's Net Worth?
The current estimated net worth of Regeneron Pharmaceuticals, Inc's EVP & General Mgr, Daniel P. van Plew, is estimated to be about $150.68M . Daniel P. van Plew owns about 22,588 units of Regeneron Pharmaceuticals, Inc common stock. In the last 16 years at Regeneron Pharmaceuticals, Inc, Daniel P. van Plew has sold an estimated value of $360.13M worth.
What is Daniel P. van Plew's Past Insider Trading?
Daniel P. van Plew's largest purchase order was 40,000 units , worth over $22.23M on September 13, 2022. Daniel P. van Plew's largest sale order was 85,579 units , worth over $47.9M on May 8, 2020. In total, Daniel P. van Plew has made about 46 transactions over 16 years of their time at Regeneron Pharmaceuticals, Inc. Daniel P. van Plew usually trades in December, with the busiest year in 2022. The most recent transaction was a sale order of 23,125 units , worth over $19.48M on August 25, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Daniel P. Van Plew
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Daniel P. van Plew's Salary in 2020?
As EVP & General Mgr of Regeneron Pharmaceuticals, Inc, Daniel P. van Plew has a total base salary of $825,577 . Daniel P. van Plew received compensation valued at about $8,654,453 in 2020 after becoming EVP & General Mgr. The vast majority of their compensation came in the form of stock awards of $3,409,560 , other earnings, plans or compensations of $938,872 , other earnings, plans or compensations of $938,872 , and other compensation of $20,945 .
What is Daniel P. van Plew's' Mailing Address?
- Mailing address is Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 NY
Regeneron Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Leonard S. Schleifer, M.D., Ph.D. | 2020 | $1,480,119 | $130,000,032 | $3,567,714 | $3,567,714 | $302,256 | $135,350,121 |
| Leonard S. Schleifer, M.D., Ph.D. | 2019 | $1,377,100 | $4,983,226 | $3,057,162 | $3,057,162 | $338,043 | $21,455,117 |
| Leonard S. Schleifer, M.D., Ph.D. | 2018 | $1,330,500 | - | $2,953,710 | $2,953,710 | $896,432 | $26,520,555 |
| George D. Yancopoulos, M.D., Ph.D. | 2020 | $1,258,096 | $130,000,032 | $3,004,391 | $3,004,391 | $120,800 | $134,383,319 |
| George D. Yancopoulos, M.D., Ph.D. | 2019 | $1,170,500 | $4,983,226 | $2,598,510 | $2,598,510 | $212,313 | $20,664,135 |
| George D. Yancopoulos, M.D., Ph.D. | 2018 | $1,130,900 | - | $2,510,598 | $2,510,598 | $399,718 | $25,381,129 |
| Robert E. Landry | 2020 | $825,577 | $949,560 | $938,872 | $938,872 | $24,195 | $6,197,703 |
| Robert E. Landry | 2019 | $730,000 | $2,840,008 | $811,395 | $811,395 | $23,470 | $7,931,542 |
| Robert E. Landry | 2018 | $680,000 | $4,767,500 | $581,400 | $581,400 | $19,535 | $9,356,619 |
| Daniel P. Van Plew | 2020 | $825,577 | $3,409,560 | $938,872 | $938,872 | $20,945 | $8,654,453 |
| Daniel P. Van Plew | 2019 | $683,100 | $2,840,008 | $759,266 | $759,266 | $20,470 | $7,829,513 |
| Daniel P. Van Plew | 2018 | $660,000 | - | $677,160 | $677,160 | $19,915 | $9,007,222 |
| Andrew J. Murphy, Ph.D. | 2020 | $726,923 | $5,025,288 | $887,250 | $887,250 | $24,195 | $10,998,914 |
| Andrew J. Murphy, Ph.D. | 2019 | $600,000 | $4,702,308 | $666,900 | $666,900 | $23,470 | $9,519,347 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm
What are Regeneron Pharmaceuticals, Inc's Past Insider Trades?
Regeneron Pharmaceuticals, Inc's most recent insider trade came on November 15, 2023 by Andrew Murphy who sold 20,000 units worth $15.94M . In the last 20 years, insiders at Regeneron Pharmaceuticals, Inc have sold an estimated value of $17.66B and bought an estimated value of $3.59B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director, Michael S Brown, Director, and P. Roy Vagelos, Director .
REGENERON PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||